ZEUS System (Zio Watch) vs Merlin.net
AI Verdict
Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System if you need to diagnose or characterize intermittent cardiac arrhythmias, particularly Atrial Fibrillation, in patients who do not have an implanted cardiac device. This wearable solution provides long-term continuous ECG and PPG data collection for up to 14 days, offering detailed insights into arrhythmia burden and providing actionable reports for initial diagnosis or ongoing management.
View ZEUS System (Zio Watch) →Choose Merlin.net if…
Choose Merlin.net if you are managing patients with existing Abbott implanted cardiac devices and require a robust remote monitoring platform. This web-based system enables clinicians to efficiently review device performance data, receive alerts for patient events, and streamline follow-up coordination, ensuring continuous oversight and informed clinical decisions for patients already utilizing Abbott's cardiac implants.
View Merlin.net →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System (Zio Watch) | Merlin.net |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Cloud-based system with a wearable device | Web-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool A (ZEUS System) offers a more comprehensive and patient-centric usability experience with its wearable Zio Watch and a dedicated MyZio patient app for symptom logging, educational content, and reminders. This approach leads to high patient compliance (99%) due to its patient-centered design. While Tool B (Merlin.net) provides clinician-focused mobile alerts and communication, its direct patient engagement features appear less prominent.
Clinical Value
ZEUS System (Zio Watch)Tool A (ZEUS System) excels in the detection and characterization of arrhythmias, particularly AFib, using an AI-powered wearable for long-term continuous monitoring. It provides clinically actionable reports with high physician agreement (99%) and has demonstrated high diagnostic yield and low retesting rates compared to other monitoring services. Tool B (Merlin.net) focuses on managing data from existing implanted cardiac devices, which serves a different, albeit valuable, clinical purpose.
Pricing & Value
ZEUS System (Zio Watch)Both tools require contacting the vendor for pricing, offering similar transparency. However, Tool A (ZEUS System) has published studies demonstrating its cost-effectiveness and high value from a health economic perspective, with an incremental cost-effectiveness ratio (ICER) of $17,000 per quality-adjusted life year gained. This evidence of economic value provides a stronger justification for its investment compared to Tool B, for which specific cost-effectiveness data was not readily available.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being cloud-based, HIPAA compliant, and offering Business Associate Agreements (BAAs). Tool A (ZEUS System) explicitly supports EHR integration via HL7 and Epic Aura, while Tool B (Merlin.net) also features EHRDirect data transfer using HL7 standards and lists compatibility with multiple major EHR systems. Their capabilities for secure data exchange and integration are comparable.
Innovation
ZEUS System (Zio Watch)Tool A (ZEUS System) showcases greater innovation by integrating an AI-powered wearable biosensor (Zio Watch) that collects both ECG and PPG data for non-invasive, long-term continuous arrhythmia detection and characterization. Its novel AI algorithm for advanced arrhythmia analysis represents a significant advancement in diagnostic technology. Tool B (Merlin.net) focuses on optimizing the management and monitoring of existing implanted cardiac devices, which is a different area of innovation.
Support & Docs
TieBoth tools offer robust support and documentation. Tool A (ZEUS System) provides 24/7 customer care, a patient app with educational content, and online instructions for use. Tool B (Merlin.net) offers detailed manuals, educational resources, and technical support via phone and email, along with integrated patient communication features. Both appear to have comprehensive resources for their respective user bases.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System (Zio Watch) | Merlin.net |
|---|---|---|
| Name | ZEUS System (Zio Watch) | Merlin.net |
| Company | iRhythm Technologies | Abbott |
| Core Purpose | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias. | Web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions. |
| Monitoring Focus | Detect and characterize Atrial Fibrillation (AFib) burden and other cardiac arrhythmias. | Remote monitoring and management of Abbott implanted cardiac devices. |
| Data Collection Method | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection | Data from Abbott implanted cardiac devices |
| AI-powered Analysis | AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis | Not specified |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and Merlin.net.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System (Zio Watch) or Merlin.net
Backers
Who funded each tool's parent company.